Location History:
- Cambridge, MA (US) (2016 - 2021)
- Brookline, MA (US) (2020 - 2023)
Company Filing History:
5 out of 2,968 
3 out of 1,210 
3 out of 315 
Years Active: 2016-2025
Title: The Innovative Contributions of Alexander Meissner
Introduction
Alexander Meissner is a prominent inventor based in Cambridge, MA, known for his significant contributions to cancer diagnostics and treatment. With a total of 8 patents to his name, Meissner has made remarkable strides in the field of epigenetics, particularly in understanding DNA methylation and its implications for cancer.
Latest Patents
Among his latest patents, Meissner has developed methods for universal early cancer diagnostics. These methods focus on quantifying DNA methylation, which can be utilized for screening diseases such as cancer, diagnosing specific cancer types, monitoring disease progression, and assessing responses to therapeutic treatments. Another notable patent involves compositions and methods for diagnosing, evaluating, and treating cancer by analyzing the DNA methylation status. This invention provides innovative approaches to determining cancer treatment prognosis by evaluating genetic and epigenetic changes within tumor samples. Furthermore, it includes methods for screening test agents that can identify compounds that decrease tumor cell plasticity.
Career Highlights
Throughout his career, Alexander Meissner has worked with esteemed institutions such as Harvard College and Dana-Farber Cancer Institute. His research has significantly advanced the understanding of cancer biology and has the potential to improve patient outcomes through more effective diagnostic and treatment strategies.
Collaborations
Meissner has collaborated with notable scientists in the field, including Rudolf Jaenisch and Yaqub Hanna. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer diagnostics.
Conclusion
In summary, Alexander Meissner's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer diagnostics and treatment. His contributions continue to pave the way for advancements in medical science and patient care.